Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

MGF (Mechano Growth Factor) peptide icon, one bubble per amino acidMGF (Mechano Growth Factor)24 residuesYQPPSTNKNTKSQRRKGSTFEERKEach bubble = one amino acid. Size = residue mass. Color = chemical class.

MGF (Mechano Growth Factor)

Beginner tier: 100 mcg, daily · 4w on / 4w off · community consensus

~5-7 minutes half-life·Injection

Also known as: MGF, IGF-1Ec, Mechano Growth Factor

Five to seven minutes. That's the entire serum half-life of native MGF (Mechano Growth Factor), the 24-amino-acid repair signal your muscles produce after hard training. When the IGF-1 gene splices under mechanical load, it releases this E-domain peptide locally at the site of tissue damage. The job is specific: activate dormant satellite cells so they can start dividing. Animal models from Goldspink's group [1] confirmed satellite cell activation and fiber hypertrophy. But the only rigorous human cell study, Fornaro 2014 [2], found zero effect on human myoblasts. Community users still report DOMS reduction and faster recovery, mostly through precise post-workout intramuscular injection.

What Is MGF (Mechano Growth Factor)?

Five to seven minutes of biological activity. That's what you get from a single injection of synthetic MGF before enzymes chew it apart. MGF, or Mechano Growth Factor (also called the IGF-1Ec E-domain peptide), is a 24-amino-acid fragment cleaved from the IGF-1 gene's Ec splice variant when muscle fibers stretch, tear, or absorb mechanical load.

The mechanism is targeted. MGF is a first-responder repair signal, arriving at the damage site within hours of exercise. Its sole early function is satellite cell activation, pushing these resident muscle stem cells out of their dormant G0 state and into the cell cycle. This happens without triggering differentiation, which comes later through a separate IGF-1Ea pathway. In murine models, Goldspink's team confirmed that MGF expression peaks within 1 to 6 hours of mechanical stimulus [1]. McKoy and colleagues showed that MGF E-peptide activates human muscle progenitor cells and increases fusion potential across different ages [3].

Then there's the catch. Fornaro and colleagues [2] tested synthetic MGF E-peptide at concentrations up to 500 ng/mL on human myoblasts and primary muscle stem cells. The result was no proliferative effect. Mature IGF-1 worked in the same assay; the synthetic E-peptide did not.

Community experience tells a different story. Across roughly 50 to 100 Reddit threads and forum discussions, users report reduced delayed-onset muscle soreness and faster session-to-session recovery. The catch: gains don't persist post-cycle, injection timing is impractical, and most experienced users eventually switch to PEG-MGF for its 48 to 72 hour half-life. All current evidence sits in the preclinical and anecdotal space. No human clinical trials have been completed.

How MGF (Mechano Growth Factor) Works

Your muscles produce MGF through alternative splicing of the IGF-1 gene. When muscle fibers experience mechanical stress, stretching, or damage, the IGF-1 gene splices to produce the Ec isoform instead of the standard Ea form. The unique 24-amino-acid E-domain peptide (MGF) gets released locally at the injury site.

Here's what makes this peptide different from systemic IGF-1. MGF does not signal through the IGF-1 receptor (IGF-1R). It uses a separate, distinct pathway to reach satellite cells, the resident stem cells responsible for muscle regeneration. Once it reaches them, MGF shifts satellite cells from their quiescent G0 state into the G1/S phase of the cell cycle. They start proliferating. They don't differentiate yet. That second step comes later, driven by the IGF-1Ea isoform acting through IGF-1R.

This two-phase system matters. MGF expands the pool of myogenic progenitor cells first. IGF-1Ea then tells that expanded pool to differentiate and begin protein synthesis. In cardiac tissue, MGF reduces apoptosis and promotes progenitor cell migration toward ischemic areas [1]. In neural tissue, it activates neural progenitor cells in the hippocampus, promoting neurogenesis in aging mouse brains [4]. The synthetic peptide replicates this E-domain signal, but the 5 to 7 minute half-life means the delivery window is extremely narrow.

MGF (Mechano Growth Factor) Benefits

  • MGF benefits center on satellite cell activation and localized muscle repair signaling.
  • Satellite cell activation without premature differentiation. MGF pushes dormant muscle stem cells into the cell cycle while leaving the differentiation step to IGF-1Ea, expanding the progenitor pool available for repair. This was confirmed in porcine satellite cell models [5].
  • Localized repair at the exact site of mechanical damage. Unlike systemic peptides, MGF is a paracrine signal, concentrating its effects where tissue tearing actually occurred.
  • DOMS reduction within 2 to 3 weeks. Community users across multiple forums consistently report less delayed-onset muscle soreness when injection timing is precise (within 5 minutes post-training).
  • Neuroprotective activity in aging brain tissue. Bhatt and colleagues confirmed that MGF promotes neurogenesis by activating neural progenitor cells in the hippocampus of aging mice [4].
  • Cardiac tissue repair after ischemic injury. Preclinical models show MGF reduces apoptosis and promotes progenitor cell migration to damaged heart tissue.
  • Complementary sequencing with IGF-1 LR3. Running a 4-week MGF cycle followed by a 4-week IGF-1 LR3 cycle covers both the proliferation and differentiation phases of muscle regeneration, a protocol widely used in community circles.

MGF (Mechano Growth Factor): Science vs Community Consensus

Divergent
Scientific Evidence
Weak
Based on 6 key studies·Research only

Animal and in-vitro models support satellite cell activation and fiber hypertrophy via the MGF E-domain.

Dosing studied: 100–300 mcg per injection (community-derived; no clinical dosing established)
Read the evidence (key study, limitations)

However, the most rigorous human cell study (Fornaro et al. 2014)[2] found zero proliferative effect of synthetic MGF E-peptide on human myoblasts or primary muscle stem cells at concentrations up to 500 ng/mL. No human clinical trials have been completed. Human efficacy is unproven.

Key Study

Fornaro M et al. 2014, Am J Physiol Endocrinol Metab (PMID 24253050): negative: synthetic MGF E-peptide had no effect on human myoblasts or primary muscle stem cells; mature IGF-1 did show effect.

Limitations

No human RCTs. Only rigorous human cell study was negative. Most positive evidence from murine models or transfected cDNA constructs, not exogenous synthetic peptide. Half-life of ~5–7 min makes in-vivo delivery poorly controlled.

Community Experience
Weak
3.0/5
Based on ~50–100 Reddit threads (r/peptides)

Mixed.

Community dosing: 100–300 mcg IM per injection, immediately post-workout near trained muscle
Read the reports (what users report 4, common issues 5)

Cautiously positive for DOMS reduction and recovery. Many users report gains do not persist post-cycle. Practical issues with 5–7 min half-life drive most experienced users to PEG-MGF instead.

What users report (4)
  • Reduced DOMS and faster post-workout recovery (anecdotal)
  • Localized hypertrophy potential via site-specific IM injection
  • Theoretical satellite cell activation / new myonuclear addition
  • Complementary to IGF-1 LR3 when sequenced in alternating cycles
Common issues (5)
  • 5–7 minute half-life mandates gym-floor injection: highly impractical
  • Gains not retained post-cycle per multiple EliteFitness/Reddit thread reports
  • Efficacy genuinely contested: Fornaro 2014 found no human myoblast effect
  • SC abdominal injection (popular shortcut) likely defeats the localized mechanism
  • Most experienced users eventually switch to PEG-MGF for practicality
Science & Community Diverge

Animal science suggested satellite cell activation; the most rigorous human cell study found no effect. Community reports modest recovery benefits, but no confirmed human mechanism exists to explain them. Science-only evidence is weak and partially negative; community use continues based on animal data extrapolation.

MGF (Mechano Growth Factor) Dosage Guide

CommunityCommunity dosing consensus from peptide research communities
LevelDose / InjectionFrequency
Beginner100 mcg
DailyTrack
Moderate200 mcg
DailyTrack
Aggressive300 mcg
DailyTrack
Note:

The 5 to 7 minute half-life changes everything about how you use this peptide. You can't bring it home from the gym. You inject within minutes of your last set, or you're wasting product.

Reconstitution math for a 2 mg vial with 1 mL bacteriostatic water: each 0.05 mL (5 units on a U-100 insulin syringe) delivers 100 mcg. For 200 mcg, draw 10 units. For 300 mcg, draw 15 units.

For a 5 mg vial with 1 mL BAC water: each 0.02 mL (2 units) delivers 100 mcg. Draw 4 units for 200 mcg, 6 units for 300 mcg.

The non-obvious thing most beginners miss: subcutaneous abdominal injection defeats the entire mechanism. MGF is a paracrine signal. It needs to be near the muscle you just trained. SC abdominal delivery leads to systemic enzymatic degradation before any peptide reaches the target tissue. Also, split your dose bilaterally when training paired muscles. One hundred mcg per side for biceps, quads, or pecs.

Keep protein intake at or above 1.8 g/kg per day. Satellite cells can't build anything without amino acid substrate.

Cycling Protocol

On Period
4 weeks
Off Period
4 weeks

Cycle 4-6 weeks on, 4 weeks off. Inject immediately post-workout near the target muscle. Due to the extremely short half-life, timing is critical: delays of even 30 minutes reduce effectiveness.

Calculate your MGF (Mechano Growth Factor) dose
Free dosage calculator with syringe visualization

Or use the universal Peptide Calculator for any peptide.

MGF (Mechano Growth Factor) Protocols by Goal

beginnerCommunity4 weeks on, 4 weeks off
On-cycle
Wk 1–4
100 mcg · Once daily post-workout · IM (localized near trained muscle)
Off-cycle
Wk 5–8
None · N/A · N/A

Expected: Modest DOMS reduction and recovery improvement (anecdotal; no controlled human data)

Monitor: Check blood glucose post-injection in early days; watch for injection site reactions.

How to Use MGF (Mechano Growth Factor)

  1. 1
    Reconstitute your vial before leaving for the gym

    Add 1 mL of bacteriostatic water to a 2 mg vial. Direct the stream against the glass wall, not the powder cake. Swirl gently. Never shake.

  2. 2
    Draw your dose into a U-100 insulin syringe

    For a 2 mg vial with 1 mL BAC water: 5 units equals 100 mcg, 10 units equals 200 mcg, 15 units equals 300 mcg. Transport the loaded syringe in an insulated pouch with a cold pack.

  3. 3
    Complete your training session

    Timing starts now.

  4. 4
    Step 4

    Within 5 minutes of your final set, inject intramuscularly into the belly of the muscle you just trained. Use a 29 or 30 gauge, 0.5 inch insulin needle. For bilateral muscles (biceps, quads, pecs), split the dose evenly between both sides.

  5. 5
    Step 5

    Rotate injection sites within the target muscle across sessions. Inspect each site before injecting for redness, warmth, or signs of infection.

  6. 6
    Step 6

    Return the reconstituted vial to the refrigerator (2 to 8 degrees Celsius) immediately upon arriving home. Use within 7 to 10 days.

  7. 7
    Step 7

    Check fasting blood glucose the morning after your first few injections. If readings drop below 70 mg/dL, reduce your dose or discontinue.

Alternative Routes

IM (intramuscular, localized)

Standard: 100–300 mcg per injection

MGF functions as a local paracrine signal at sites of mechanical damage. Injection near the trained muscle is necessary for any potential localized effect. Split dose bilaterally for paired muscle groups.

SC (subcutaneous, abdominal)

Same dose range but most peptide is degraded systemically before reaching target muscle

Community guides consistently cite SC abdominal injection as the top user mistake. Some users accept this route for convenience despite likely absent localized effect. Mechanistically unsound for native MGF.

Mixing your own vial? Use the MGF (Mechano Growth Factor) reconstitution calculator for the exact BAC-water-to-mcg math on any vial size.

MGF (Mechano Growth Factor) Stacking Protocols

Works With

Avoid

IGF-1 LR3 (concurrent same-day)

MGF E-domain and IGF-1 LR3 act on overlapping satellite cell receptor pathways. Same-day co-administration may cause receptor competition and reduce the proliferative effect of MGF. Stagger by ≥4–6 hours or run in separate cycles.

Insulin / Sulfonylureas

MGF carries an independent hypoglycemia risk at higher doses. Combining with exogenous insulin or insulin secretagogues significantly increases hypoglycemia risk through additive glucose-lowering effects.

Do not combine

Estimated Cost

Generic / Research
~$28–38/vial (2mg research grade); ~$75–120/vial (5mg research grade): unregulated research market

Pricing updated 2026-04-09

MGF (Mechano Growth Factor) Side Effects

The biggest concern with MGF isn't a side effect you'll feel. It's what you can't measure. No human clinical trials have ever been completed for synthetic MGF. The total body of human-relevant evidence amounts to one rigorous in-vitro study (Fornaro 2014)[2] and community anecdotes. Long-term human safety data does not exist. You're operating without a safety net.

Hypoglycemia is the most medically actionable risk. MGF activates the IGF-1 pathway, which lowers blood glucose. At higher doses (200 to 300 mcg range), users should monitor fasting blood glucose, especially during the first week. Anyone stacking MGF with other IGF-1 pathway peptides, insulin, or sulfonylureas faces compounded risk. If you feel dizzy, sweaty, or confused post-injection, check your blood sugar immediately. That's not "feeling the peptide working." That's hypoglycemia.

Injection site reactions are common. Daily intramuscular injections into the same muscle group create localized pain, redness, and swelling. Multiple sites per session (bilateral dosing) increases exposure. Rotate sites within the target area and inspect before each injection for signs of infection, granuloma, or abscess.

Water retention and temporary bloating show up in community reports. So does joint pain and stiffness, particularly at higher doses.

Fatigue and flu-like symptoms appear in some users, especially early in the cycle. These typically resolve by week 2.

MGF promotes cell proliferation. That's the entire point, and it's also the reason it's contraindicated in anyone with active cancer, a history of malignancy, or uncontrolled cell growth of any kind. This applies to all IGF-1 pathway peptides without exception.

Pregnancy and breastfeeding are absolute contraindications. Children and adolescents with open growth plates should not use MGF. Anyone with uncontrolled diabetes or known hypersensitivity to IGF-1 or related peptides should avoid it entirely.

When to stop: if you experience hypoglycemia, signs of infection at the injection site, worsening joint pain, or no perceived benefit by the end of week 3.

Glucocorticoids (prednisone, dexamethasone) may block the growth-promoting effects of MGF. Anticoagulant users should monitor for increased bruising at injection sites.

Common Issues & Solutions

Injection must occur within 5 minutes of the final set: native MGF has a ~5–7 minute half-life. Returning home before injecting eliminates any potential localized effect.

Use IM injection near the target muscle, not subcutaneous abdominal: SC abdominal delivery leads to near-complete systemic enzymatic degradation before reaching the trained muscle.

Split dose bilaterally (e.g., 100 mcg/side) when training paired muscle groups (biceps, quads, pecs): localized paracrine signaling requires proximity to mechanical damage.

Do not combine MGF and IGF-1 LR3 in the same injection window: receptor competition at the satellite cell level; alternate in 4-week cycles instead.

Maintain protein intake ≥1.8 g/kg/day during cycle: satellite cells cannot build muscle without adequate amino acid substrate; MGF without sufficient protein is ineffective regardless of dose.

Ask AI about this page

Ask AI for a second opinion on MGF (Mechano Growth Factor) dosing and side effects

Contraindications

  • Active cancer or history of any malignancy (MGF promotes cell proliferation)
  • Pregnancy or breastfeeding
  • Known hypersensitivity to IGF-1 or related peptides
  • Uncontrolled diabetes or hypoglycemia-prone individuals
  • Children and adolescents (open growth plates)
  • Active infections at the intended injection site

Drug Interactions

  • Insulin and sulfonylureas: increased hypoglycemia risk from additive glucose-lowering effects
  • Glucocorticoids (prednisone, dexamethasone): may inhibit the growth-promoting effect of MGF
  • Other IGF-1 pathway peptides (IGF-1 LR3, HGH): potential for compounded mitogenic effects; avoid stacking without medical oversight
  • Anticoagulants: monitor for increased bruising at injection sites

Product Quality

Recommended Monitoring

TestWhenTarget
Fasting blood glucoseBaseline before starting; recheck at day 7 and week 470–100 mg/dL fasting
Injection site inspectionBefore each injection sessionNot listed
Serum IGF-1Optional: baseline and end of 4-week cycle, especially if stacking with IGF-1 LR3Age-adjusted normal range (typically 115–307 ng/mL for adults)
Fasting blood glucose

MGF carries a hypoglycemia risk at higher doses via IGF-1 pathway activation; additive risk if stacking with other IGF-1 pathway peptides.

Injection site inspection

Daily IM injections risk infection, granuloma formation, or abscess: particularly with multiple injection sites per session.

Serum IGF-1

MGF activates IGF-1 pathway; combined use with IGF-1 LR3 can compound pathway stimulation; baseline helps assess net exposure.

MGF (Mechano Growth Factor) Before and After

Weeks 1-2

Initial adaptation period. Injection site soreness is common early on. No measurable muscle changes expected. Users may notice mild post-workout soreness reduction if injection timing is correct.

Weeks 3-4

Anecdotal reports of improved recovery between sessions and reduced delayed-onset muscle soreness (DOMS). No clinical data supports specific timelines. Effects are highly dependent on injection site and timing.

Weeks 5-6

End of typical cycle. Some users report improved training capacity and recovery. Any observed effects are anecdotal: no controlled human trials exist to validate timelines. Begin taper or transition to off-cycle period.

Off-cycle
4 weeks

Allow receptor sensitivity to normalize. Maintain training volume. Some users stack with BPC-157 or TB-500 during the off-cycle for continued recovery support.

What to Expect

Days 1 through 7, Injection Site Adaptation: Don't expect anything measurable this first week. Your body is adapting to the injection protocol, not building muscle. Mild soreness at the injection site is normal; so is light fatigue. Science has no human timeline data to offer here. Some community users report reduced post-workout fatigue by day 4 or 5, but set your expectations low.

Weeks 2 through 3, Recovery Improvement Window: This is where community reports start getting interesting. Users who nail the timing (within 5 minutes post-training, IM into the target muscle) describe noticeable DOMS reduction and faster session-to-session recovery. Animal models show peak satellite cell activation within 1 to 6 hours of mechanical stimulus, which lines up with the theoretical window. But "interesting anecdotes" and "proven human endpoints" are very different things.

Week 4, Peak Cycle Effects: End of a standard cycle. Some users report improved training capacity and a mild fullness in trained muscles. Multiple EliteFitness and Reddit threads flag an honest warning: the gains are not retained post-cycle. No human biomarker data exists for synthetic MGF at any timepoint.

Weeks 5 through 8, Off-Cycle Recovery: Reported benefits fade within 1 to 2 weeks off. This is expected given receptor sensitivity normalization. Many users transition to BPC-157 or TB-500 during the off-cycle for continued recovery support. No human data exists on withdrawal or rebound effects.

Detailed Timeline: Science vs Community

Days 1–7
Science

No measurable anabolic changes. Adaptation period only.

Community

Mild injection site soreness common. Some users report reduced post-workout fatigue.

Weeks 2–3
Science

No human clinical timeline data. Animal models show peak satellite cell activation 1–6 hours post-stimulus.

Community

Anecdotal DOMS reduction and faster session-to-session recovery. Effect highly dependent on injection timing accuracy and site specificity.

Week 4 (end of cycle)
Science

No human clinical endpoints. No measurable biomarker data for synthetic MGF in humans.

Community

Some users report improved training capacity and mild muscle fullness. Multiple forum threads note gains are NOT retained post-cycle.

Off-cycle (Weeks 5–8)
Science

Receptor sensitivity normalization. No human withdrawal or rebound data.

Community

Reported benefits fade within 1–2 weeks off. Many users transition to BPC-157 or TB-500 for continued recovery support during the off-cycle.

Pharmacokinetics

Half-Life
6min
Bioavailability
IM (localized): not formally characterized; rapidly degraded systemically
Tmax
<5 minutes
Data Confidence
low

Source: Estimated ~5-7 minutes; Matheny et al., Endocrinology 2010 (PMID 20130113)

Pharmacokinetics: Active Dose Over Time

t½ = ~5-7 minutes

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.

Molecular Profile

Amino Acids
24
Sequence
YQPPSTNKNTKSQRRKGSTFEERK
HydrophobicPolarPositiveNegativeSpecialHow we generate these icons
Identifiers
CAS: not available (no CAS assigned for the synthetic 24-aa E-domain fragment)

Who Should Consider MGF (Mechano Growth Factor)

  • Athletes and bodybuilders seeking accelerated muscle recovery
  • Researchers studying satellite cell biology and muscle regeneration
  • Adults with age-related muscle wasting (sarcopenia): preclinical interest
  • Individuals recovering from muscle injuries: preclinical interest
  • Cardiac researchers investigating post-ischemic tissue repair

Related Peptides

What Changed for MGF (Mechano Growth Factor)

No material change since Oct 5, 2026. Checked against Federal Register, openFDA Drugs@FDA, openFDA drug labels, openFDA enforcement reports and PubMed retraction links on Oct 14, 2026. How the change record works

Peptide Schedule Research TeamReviewed Apr 7, 20266 Citations

References

  1. [1]Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration (Endocrinology 2010) (opens in a new tab)PubMed (opens in a new tab)PubMed
  2. [2]Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells (Am J Physiol Endocrinol Metab 2014) (opens in a new tab)PubMed (opens in a new tab)PubMed
  3. [3]MGF E peptide activates human muscle progenitor cells and induces an increase in their fusion potential at different ages (Mech Ageing Dev 2011) (opens in a new tab)PubMed (opens in a new tab)PubMed
  4. [4]Mechano growth factor, a splice variant of IGF-1, promotes neurogenesis in the aging mouse brain (Mol Brain 2017) (opens in a new tab)PubMed (opens in a new tab)PubMed
  5. [5]MGF promotes proliferation and inhibits differentiation of porcine satellite cells by down-regulation of key myogenic transcriptional factors (Mol Cell Endocrinol 2012) (opens in a new tab)PubMed (opens in a new tab)PubMed

Related Tools

Storage & Stability

Before Reconstitution
Refrigerate at 2-8°C or freeze at -20°C for long-term storage
After Reconstitution
Refrigerate at 2-8°C, use within 7-10 days
Temperature
2-8°C (36-46°F)

Frequently Asked Questions

Yes, timing is everything. Native MGF has a serum half-life of about 5-7 minutes, meaning it's enzymatically destroyed almost immediately. You need to inject within minutes of finishing your training session. Delays of even 30 minutes meaningfully reduce any potential localized effect. This impracticality is the main reason most experienced users switch to PEG-MGF.

MGF (Mechano Growth Factor) dosing varies by experience level. Beginners typically start at 100 mcg daily, moderate users at 200 mcg daily, and aggressive protocols use 300 mcg daily.

MGF (Mechano Growth Factor) typically comes in 2mg or 5mg vials. Add 1mL of bacteriostatic water to the vial. Use the free calculator for exact syringe units based on your desired dose.

The half-life of MGF (Mechano Growth Factor) is ~5-7 minutes. This determines how frequently you need to dose for consistent blood levels.

The biggest concern with MGF isn't a side effect you'll feel. It's what you can't measure. No human clinical trials have ever been completed for synthetic MGF. The total body of human-relevant evidence amounts to one rigorous in-vitro study (Fornaro 2014, PMID 24253050) and community anecdotes. Long-term human safety data does not exist. You're operating without a safety net. Hypoglycemia is the most medically actionable risk. MGF activates the IGF-1 pathway, which lowers blood glucose. At higher doses (200 to 300 mcg range), users should monitor fasting blood glucose, especially during the first week. Anyone stacking MGF with other IGF-1 pathway peptides, insulin, or sulfonylureas faces compounded risk. If you feel dizzy, sweaty, or confused post-injection, check your blood sugar immediately. That's not "feeling the peptide working." That's hypoglycemia. Injection site reactions are common. Daily intramuscular injections into the same muscle group create localized pain, redness, and swelling. Multiple sites per session (bilateral dosing) increases exposure. Rotate sites within the target area and inspect before each injection for signs of infection, granuloma, or abscess. Water retention and temporary bloating show up in community reports. So does joint pain and stiffness, particularly at higher doses. Fatigue and flu-like symptoms appear in some users, especially early in the cycle. These typically resolve by week 2. MGF promotes cell proliferation. That's the entire point, and it's also the reason it's contraindicated in anyone with active cancer, a history of malignancy, or uncontrolled cell growth of any kind. This applies to all IGF-1 pathway peptides without exception. Pregnancy and breastfeeding are absolute contraindications. Children and adolescents with open growth plates should not use MGF. Anyone with uncontrolled diabetes or known hypersensitivity to IGF-1 or related peptides should avoid it entirely. When to stop: if you experience hypoglycemia, signs of infection at the injection site, worsening joint pain, or no perceived benefit by the end of week 3. Glucocorticoids (prednisone, dexamethasone) may block the growth-promoting effects of MGF. Anticoagulant users should monitor for increased bruising at injection sites.